Found 11 matching trials
A PhaseⅡ Study to Evaluate the Safety & Immunogenicity of SARS-CoV-2 Alpha/Beta/Delta/Omicron Variants COVID-19 Vaccine PHASE2 This study is a randomized, double-blind, placebo-controlled Phase II clini...
Show More Location
Lianshui County Center for Disease Control and Prevention
Learn More & Join Trial
A Study to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E (Two Recombinant Protein COVID-19 Vaccines) in Population Aged ≥12 Years PHASE2 The objective of the study is to evaluate the immunogenicity and safety of ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety of SCTV01E (a COVID-19 Vaccine) in Population Aged ≥18 Years PHASE3 The objective of this study is to evaluate the effectiveness of SCTV01E in ...
Show More Location
Guizhou center for disease control and prevention
Learn More & Join Trial
A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01E in Population Aged ≥18 Years Previously Fully Vaccinated With mRNA COVID-19 Vaccine PHASE2 The objective of this study is to evaluate the immunogenicity and safety of...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase III Clinical Trial to Evaluate the Efficacy and Safety of SCTV01E in Healthy People PHASE3 The objective of this study is to evaluate the effectiveness of SCTV01E in ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine SCTV01E-1 in Population Aged Above 18 Years PHASE2 The study is a randomized, double-blind Phase II study. It will evaluate th...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E in Population Aged ≥12 Years Previously Fully Vaccinated With Inactivated COVID-19 Vaccine PHASE2 The objective of study is to evaluate the immunogenicity and safety of SCTV...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Immunogenicity and Safety of A Recombinant Protein COVID-19 Vaccine as Booster Vaccines PHASE2 This study is a phase Ⅱ clinical trial to evaluate the safety and immunogen...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine in Population Aged ≥18 Years PHASE2 The study is a randomized, double-blind, positive-controlled Phase II boost...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster Vaccines PHASE3 The study is a randomized, double-blind, and positive-controlled Phase III ...
Show More Location
Al Kuwait Hospital (Al Baraha Hospital)
Learn More & Join Trial